NATERA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.72 USD | -0.46% |
|
+2.67% | +49.62% |
| May. 01 | Natera, Inc. Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage | CI |
| Apr. 18 | Natera Insider Sold Shares Worth $7,265,651, According to a Recent SEC Filing | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,612 | 8,496 | 8,834 | 4,380 | 7,526 | 11,456 | - | - |
| Enterprise Value (EV) 1 | 2,295 | 8,011 | 8,250 | 3,843 | 6,997 | 11,045 | 10,954 | 10,701 |
| P/E ratio | -18.8 x | -35 x | -17.9 x | -7.21 x | -16.6 x | -40.5 x | -80.5 x | -1,011 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 8.64 x | 21.7 x | 14.1 x | 5.34 x | 6.95 x | 8.55 x | 7.21 x | 6.16 x |
| EV / Revenue | 7.59 x | 20.5 x | 13.2 x | 4.69 x | 6.46 x | 8.24 x | 6.9 x | 5.76 x |
| EV / EBITDA | -18.7 x | -38.6 x | -18.1 x | -7.33 x | -16.6 x | -42.2 x | -95.4 x | 364 x |
| EV / FCF | -33.5 x | -39.6 x | -21.4 x | -8.02 x | -24.5 x | -87.4 x | 371 x | 64 x |
| FCF Yield | -2.98% | -2.52% | -4.66% | -12.5% | -4.09% | -1.14% | 0.27% | 1.56% |
| Price to Book | 9.43 x | 16.6 x | 13.6 x | 6.33 x | 9.79 x | 16.6 x | 15.5 x | 12.1 x |
| Nbr of stocks (in thousands) | 77,529 | 85,370 | 94,595 | 109,033 | 120,152 | 122,242 | - | - |
| Reference price 2 | 33.69 | 99.52 | 93.39 | 40.17 | 62.64 | 93.72 | 93.72 | 93.72 |
| Announcement Date | 2/26/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 302.3 | 391 | 625.5 | 820.2 | 1,083 | 1,340 | 1,588 | 1,858 |
| EBITDA 1 | -122.9 | -207.7 | -456.9 | -524.3 | -422.1 | -261.9 | -114.8 | 29.39 |
| EBIT 1 | -130.7 | -216.3 | -468.2 | -541 | -446.2 | -289.4 | -149.3 | -21.88 |
| Operating Margin | -43.22% | -55.31% | -74.85% | -65.96% | -41.22% | -21.6% | -9.4% | -1.18% |
| Earnings before Tax (EBT) 1 | -122.8 | -229.6 | -471.1 | -546.8 | -434.5 | -280 | -140.4 | -0.0793 |
| Net income 1 | -124.8 | -229.7 | -471.7 | -547.8 | -434.8 | -280.3 | -141.5 | -9.049 |
| Net margin | -41.29% | -58.76% | -75.42% | -66.79% | -40.16% | -20.92% | -8.91% | -0.49% |
| EPS 2 | -1.790 | -2.840 | -5.210 | -5.570 | -3.780 | -2.315 | -1.165 | -0.0927 |
| Free Cash Flow 1 | -68.41 | -202.1 | -384.8 | -479.2 | -286.2 | -126.4 | 29.56 | 167.1 |
| FCF margin | -22.63% | -51.69% | -61.52% | -58.42% | -26.43% | -9.43% | 1.86% | 8.99% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 568.75% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/26/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 158.1 | 173 | 194.1 | 198.2 | 210.6 | 217.3 | 241.8 | 261.4 | 268.3 | 311.1 | 315.3 | 328.1 | 339.1 | 356.3 | 373 |
| EBITDA 1 | -147.2 | -136.7 | -134.1 | -138.5 | -113.9 | -137.8 | -133.2 | -107.3 | -104 | -77.62 | -90.86 | -75.32 | -65.9 | -54.34 | -39.34 |
| EBIT 1 | -150.2 | -139.7 | -137.1 | -143.1 | -119.1 | -141.8 | -138.3 | -112.4 | -111 | -84.54 | -86.7 | -77.69 | -68.69 | -56.82 | -54.88 |
| Operating Margin | -94.99% | -80.72% | -70.64% | -72.19% | -56.52% | -65.26% | -57.21% | -43.01% | -41.36% | -27.17% | -27.49% | -23.68% | -20.26% | -15.95% | -14.72% |
| Earnings before Tax (EBT) 1 | -151 | -140.6 | -138.4 | -145 | -121.3 | -142.2 | -136.8 | -111.1 | -108.8 | -77.84 | -86.57 | -76.84 | -66.97 | -53.97 | -52.51 |
| Net income 1 | -151.3 | -140.6 | -138.6 | -145.2 | -121.5 | -142.6 | -136.9 | -110.8 | -109 | -78.03 | -86.03 | -75.6 | -65.86 | -53.81 | -52.57 |
| Net margin | -95.67% | -81.24% | -71.39% | -73.23% | -57.67% | -65.63% | -56.64% | -42.39% | -40.64% | -25.08% | -27.28% | -23.05% | -19.42% | -15.1% | -14.1% |
| EPS 2 | -1.630 | -1.490 | -1.450 | -1.500 | -1.250 | -1.370 | -1.230 | -0.9700 | -0.9500 | -0.6400 | -0.7183 | -0.6294 | -0.5483 | -0.4432 | -0.4181 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/24/22 | 5/5/22 | 8/4/22 | 11/8/22 | 2/28/23 | 5/9/23 | 8/3/23 | 11/8/23 | 2/28/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 317 | 485 | 584 | 536 | 529 | 411 | 502 | 756 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -68.4 | -202 | -385 | -479 | -286 | -126 | 29.6 | 167 |
| ROE (net income / shareholders' equity) | -89.6% | -60.1% | -82.8% | -80.6% | -59.1% | -39.2% | -13.8% | 3.23% |
| ROA (Net income/ Total Assets) | -32.7% | -30.3% | -43.5% | -41.6% | -30.7% | -21.4% | -8.6% | -1.1% |
| Assets 1 | 381.4 | 757.4 | 1,084 | 1,315 | 1,418 | 1,313 | 1,646 | 822.6 |
| Book Value Per Share 2 | 3.570 | 6.000 | 6.870 | 6.340 | 6.400 | 5.640 | 6.050 | 7.760 |
| Cash Flow per Share 2 | -0.9100 | -2.250 | -3.700 | -4.380 | -2.150 | -0.2600 | 0.6300 | 2.200 |
| Capex 1 | 4.97 | 19.6 | 49.6 | 47.7 | 39.2 | 41.9 | 50.9 | 56.9 |
| Capex / Sales | 1.64% | 5.01% | 7.93% | 5.82% | 3.62% | 3.13% | 3.2% | 3.06% |
| Announcement Date | 2/26/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
93.72
USD
Average target price
103.4
USD
Spread / Average Target
+10.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +49.62% | 11.46B | |
| +14.10% | 81.68B | |
| -30.15% | 69.23B | |
| +9.37% | 29.08B | |
| -11.90% | 16.88B | |
| +0.50% | 16.85B | |
| -1.12% | 15.15B | |
| +6.43% | 12.62B | |
| +35.78% | 12.47B | |
| -3.66% | 11.66B |
- Stock Market
- Equities
- NTRA Stock
- Financials Natera, Inc.
